Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited13.4229656076115.2857
Domestic EquitiesApollo Hospitals Enterprise Limited7.33688493663.0140
Domestic EquitiesTorrent Pharmaceuticals Limited5.033810244643.2343
Domestic EquitiesJ.B. Chemicals & Pharmaceuticals Limited4.987120748442.8330
Domestic EquitiesAurobindo Pharma Limited4.423429125437.9912
Domestic EquitiesAjanta Pharmaceuticals Limited4.223412931236.2733
Domestic EquitiesLupin Limited4.208615621436.1464
Domestic EquitiesIPCA Laboratories Limited4.105122019735.2579
Domestic EquitiesAbbott India Limited3.90231293333.5159
Domestic EquitiesFortis Healthcare Limited3.494937756430.0163
Domestic EquitiesEmcure Pharmaceuticals Ltd3.302117775728.3611
Domestic EquitiesCipla Limited3.237022709827.8013
Domestic EquitiesMankind Pharma Ltd2.932612557425.1876
Domestic EquitiesShilpa Medicare Ltd2.262655696419.4325
Domestic EquitiesAlkem Laboratories Limited2.16183503918.5672
Domestic EquitiesCORONA Remedies Ltd2.119111697018.2005
Domestic EquitiesSAI Life Sciences Ltd2.093518498817.9808
Domestic EquitiesProcter & Gamble Health Limited1.96653519516.8894
Domestic EquitiesJupiter Life Line Hospitals Ltd1.960213140816.8360
Domestic EquitiesDivi's Laboratories Limited1.80032600015.4622
Domestic EquitiesSANOFI CONSUMER HEALTHCARE1.57933155713.5638
Domestic EquitiesDr. Reddys Laboratories Limited1.44619897512.4204
Domestic EquitiesThyrocare Technologies Limited1.443135457912.3943
Domestic EquitiesPfizer Limited1.40472555812.0647
Domestic EquitiesMETROPOLIS HEALTHCARE LIMITED1.357526864011.6590
Domestic EquitiesALEMBIC PHARMACEUTICALS LIMITED1.243716105710.6821
Domestic EquitiesBiocon Limited1.14132716159.8026
Domestic EquitiesJubilant Pharmova Ltd1.11111168869.5432
Domestic EquitiesANTHEM BIOSCIENCES LIMITED1.08261416849.2980
Domestic EquitiesGland Pharma Limited0.9874500008.4805
Domestic EquitiesPiramal Pharma Ltd0.91895780007.8920
Domestic EquitiesMedi Assist Healthcare Services Ltd0.90362615277.7608
Domestic EquitiesSuraksha Diagnostic Ltd0.88843347367.6303
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited0.8718327977.4876
Domestic EquitiesVijaya Diagnostic Centre Limited0.7844782106.7370
Domestic EquitiesMax Healthcare Institute Limited0.7843700006.7361
Domestic EquitiesVinati Organics Limited0.7281472226.2536
Total 97.6505 838.6926
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Limited2.1769 18.6969
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)0.1726 1.4824
Total 2.3495 20.1793
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.